Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma Interventions:   Drug: Idarubicin Hydrochloride for Injection;   Drug: Epirubicin Sponsor:   Zhejiang Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials